Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: EC:6.3.4.6 (urease)
 7,490 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

Extensive cultures of stones and urine were performed in 215 patients who underwent an operation for upper urinary tract calculi. Microorganisms could be cultured from the stone in 1 of every 3 patients. Despite the extended culture technique urease-producing microorganisms could be cultured from the stone in only 48% of the patients with calculi that contained magnesium ammonium phosphate. This finding suggests that an infection with urease-producing microorganisms is not obligatory for the formation of this type of stone. Of the patients with calcium oxalate phosphate stones 32% had positive stone cultures, which distinguished them from patients with pure calcium oxalate stones, only 8% of whom had a positive stone culture (p less than 0.001).
 ...
PMID:Bacteriology of upper urinary tract stones. 232 12

With the increase of extremely specific polypeptide drugs arising from advances in recombinant DNA techniques, there exists a need with which to optimally deliver these genetically engineered drugs. This results from the normally short circulating half-life of these macromolecules. A well characterized model enzyme, urease, was formulated in a 20, 30, and 35% w/w poloxamer 407 gel matrix and the release profile determined in a membraneless diffusion system (Area = 11.4 cm2) in vitro at 37 degrees C over 8 hours. Polymer release into a pH = 7.0 phosphate buffer receptor phase due to matrix erosion was constant throughout 8 hours and ranged from 1.07% +/- 0.04 cm-2 hr-1 to 0.48% +/- 0.02 cm-2 hr-1 for the 20% w/w and 35% w/w poloxamer gel matrices, respectively. The predominant mechanism governing release of protein from the semisolid, poloxamer 407 gel matrix in vitro was matrix erosion with the cumulative urease released ranging from 89.5% +/- 3.5 after 7 hours (20% w/w, n = 3) to 46.6% +/- 0.3 following 8 hours of released (35% w/w, n = 3), respectively. The percent relative biological activity of the enzyme [(Act.poly/Act.cont)*100] remaining was determined following incubation in a 14% w/w concentration of poloxamer 407 for 8 hours at 4, 22, and 37 degrees C. The percent relative enzyme activity remaining following incubation in the 14% w/w poloxamer 407 solution after 8 hours was not significantly different (p greater than 0.05) between samples incubated at 4 degrees C (94.2% +/- 2.4) and 37 degrees C (89.7% +/- 1.7). Hydrodynamic properties of dilute urease and poloxamer 407 solutions were assessed using viscometry.(ABSTRACT TRUNCATED AT 250 WORDS)
 ...
PMID:Sustained-release of urease from a poloxamer gel matrix. 233 5

Urease with a purity meeting the requirements of analytical use was purified from jack bean meal through steps consisting of 20% acetone extraction, heat treatment, acid precipitation, and lyophilization. For extraction of urease, one part of bean meal was mixed with 5 parts of 20% acetone containing 1 mM EDTA and 1 mM 2-mercaptoethanol, and stirred at 20 degrees C for 5 min. Milky substances in the extract were removed by heat treatment. Urease in the clear yellow supernatant was precipitated by adjusting the pH of the solution to 5.4 with citric acid. The acid precipitated urease was neutralized by dissolving in 0.015 M phosphate buffer, pH 8.5 (final pH 6.8 to 7.0) and then lyophilized. By this procedure, the purity of the enzyme was increase 14.7 fold, the recovery of activity was 63%, and the yield was 6.75 g from 1 kg of bean seeds. The specific activity of the preparation was 411 units/mg protein (240 units/mg solid), and the free ammonia content was less than 0.01 microgram per unit. Some other proteins were present in the urease preparation as examined by gel filtration and gradient polyacrylamide gel electrophoresis. The molecular weight of the enzyme estimated by gel filtration was 480,000. However, two urease activity bands with molecular weight of 230,000 and 480,000 were observed in the polyacrylamide gel electrophoregram. From the result of determination of blood urea nitrogen (BUN), this simple purification procedure could be used for practical preparation of urease from jack bean meal for clinical analysis.
 ...
PMID:A procedure for purifying jack bean urease for clinical use. 251 64

Elasmobranch fishes, the coelacanth, estivating lungfish, amphibians, and mammals synthesize urea by the ornithine-urea cycle; by comparison, urea synthetic activity is generally insignificant in teleostean fishes. It is reported here that isolated liver cells of two teleost toadfishes, Opsanus beta and Opsansus tau, synthesize urea by the ornithine-urea cycle at substantial rates. Because toadfish excrete ammonia, do not use urea as an osmolyte, and have substantial levels of urease in their digestive systems, urea may serve as a transient nitrogen store, forming the basis of a nitrogen conservation shuttle system between liver and gut as in ruminants and hibernators. Toadfish synthesize urea using enzymes and subcellular distributions similar to those of elasmobranchs: glutamine-dependent carbamoyl phosphate synthethase (CPS III) and mitochondrial arginase. In contrast, mammals have CPS I (ammonia-dependent) and cytosolic arginase. Data on CPS and arginases in other fishes, including lungfishes and the coelacanth, support the hypothesis that the ornithine-urea cycle, a monophyletic trait in the vertebrates, underwent two key changes before the evolution of the extant lungfishes: a switch from CPS III to CPS I and replacement of mitochondrial arginase by a cytosolic equivalent.
 ...
PMID:Evolution of urea synthesis in vertebrates: the piscine connection. 256 72

Staphylococcal cell protein and urease can be solubilized after growth in Todd-Hewitt broth supplemented with 0.5% yeast extract by extraction for 18-24 h in phosphate buffer, pH 7.0. In general 20% (but up to 100%) of the urease present in the original cells could be solubilized. Less protein was solubilized. Species examined included coagulase-negative staphylococci, Staphylococcus intermedius and Staph. aureus. Extracts of Staph. epidermidis prepared by this procedure gave electrophoretic urease and protein patterns similar to those prepared by sonication. The procedure was simple and minimized handling of the cells.
 ...
PMID:A procedure for urease and protein extraction from staphylococci. 258 72

We examined several compounds for their mechanisms of inhibition with the nickel-containing active site of homogeneous Klebsiella aerogenes urease. Thiolate anions competitively inhibit urease and directly interact with the metallocenter, as shown by the pH dependence of inhibition and by UV-visible absorbance spectroscopic studies. Cysteamine, which possesses a cationic beta-amino group, exhibited a high affinity for urease (Ki = 5 microM), whereas thiolates containing anionic carboxyl groups were uniformly poor inhibitors. Phosphate monoanion competitively inhibits a protonated form of urease with a pKa of less than 5. Both the thiolate and phosphate inhibition results are consistent with charge repulsion by an anionic group in the urease active site. Acetohydroxamic acid (AHA) was shown to be a slow-binding competitive inhibitor of urease. This compound forms an initial E.AHA complex which then undergoes a slow transformation to yield an E.AHA* complex; the overall dissociation constant of AHA is 2.6 microM. Phenylphosphorodiamidate, also shown to be a slow-binding competitive inhibitor, possesses an overall dissociation constant of 94 pM. The tight binding of phenylphosphorodiamidate was exploited to demonstrate the presence of two active sites per enzyme molecule. Urease contains 4 mol of nickel/mol enzyme, hence there are two nickel ions/catalytic unit. Each of the two slow-binding inhibitors are proposed to form complexes in which the inhibitor bridges the two active site nickel ions. The inhibition results obtained for K. aerogenes urease are compared with inhibition studies of other ureases and are interpreted in terms of a model for catalysis proposed for the jack bean enzyme (Dixon, N.E., Riddles, P.W., Gazzola, C., Blakely, R.L., and Zerner, B. (1980) Can. J. Biochem. 58, 1335-1344).
 ...
PMID:Competitive inhibitors of Klebsiella aerogenes urease. Mechanisms of interaction with the nickel active site. 267 18

Zinc reduced and citrate promoted the urease-induced pH increase in synthetic urine. Secondary to this, the precipitation of magnesium ammonium phosphate and calcium phosphate was influenced. Independent of this pH-related effect, zinc also increased the precipitation of magnesium ammonium phosphate and decreased the calcium phosphate precipitation. These observations were not totally reproducable in human urine.
 ...
PMID:The influence of zinc and citrate on urease-induced urine crystallisation. 274 46

Long-term indwelling urinary catheters may become blocked in some patients by formation of encrustations made up of aggregated struvite crystals while other patients rarely develop blocked catheters. We have designated these groups as "blockers", "intermediates" or "non-blockers". To further understand this phenomenon we followed 32 catheterized elderly women in a nursing home. Catheters were changed six times at 2 week intervals. Patients tended to remain as "blockers", "intermediates" or "non-blockers" consistently over time. There were no significant differences in use of antibiotics, clinical manifestations of urinary infection or fever among the groups. "Blockers" were significantly more often colonized with Proteus mirabilis and Providencia stuartii than "non-blockers", and significantly less often with Klebsiella pneumoniae. However, there was no evidence of interference among the organisms. "Blockers" excreted a significantly more alkaline urine, and lesser amounts of magnesium, urea and phosphate in their urine. Two "blockers" in whom Proteus sp. were eliminated by coincidental antimicrobial therapy converted to "non-blockers". These findings support the concept that "blockers" are patients who have prolonged colonization with urease producing Proteus mirabilis and Providencia stuartii.
 ...
PMID:Blockage of urinary catheters: role of microorganisms and constituents of the urine on formation of encrustations. 277 65

Hyperammonemia is a major contributing factor to the neurological abnormalities observed in hepatic encephalopathy and in congenital defects of ammonia detoxication. In rats variable changes in labile energy rich phosphates in the brain have been observed in hyperammonemia using biochemical methods. Using 31P-NMR spectroscopy however no significant changes of the relative concentrations of the energy rich phosphates alpha, beta and gamma-ATP, phosphocreatine, inorganic phosphate and the pH were found in the fronto parietal cortex of the urease treated hyperammonemic rat. Alterations in the metabolites of these compounds do not appear to be a major pathomechanism of ammonia toxicity in this brain area.
 ...
PMID:In vivo 31P NMR spectroscopy of energy rich phosphates in the brain of the hyperammonemic rat. 293 May 44

Experimental and clinical studies have been performed to determine whether Ureaplasma urealyticum has an etiological role in the development of infection stones in the urinary tract. Incubation of synthetic urine in vitro with U. urealyticum caused alkalinization of the urine and crystallization of struvite and calcium phosphate. Inoculation of U. urealyticum into rat bladders resulted in the formation of struvite stones in 84% of the rats. Furthermore, infection with U. urealyticum markedly increased the adherence of urease-induced crystals to the bladder epithelium compared to normal rat bladders, probably due to elimination of the mucous coat which covers the normal urothelium. Clinically, U. urealyticum has been cultured from voided urine and from the stone in patients operated on for renal stones. U. urealyticum was cultured in voided urine in 31 of 247 patients (13%) with metabolic stones, compared to 43 of 145 patients (30%) with infection stones (p less than 0.001). In the patients where stone cultures were performed, U. urealyticum was found in 2 of 125 patients (2%) with metabolic stones, compared to 10 of 64 patients (16%) with infection stones (p less than 0.001). These observations strongly suggest that U. urealyticum is linked to the formation of infection stones in the urinary tract.
 ...
PMID:Urinary infection stones caused by Ureaplasma urealyticum: a review. 304 57


<< Previous 1 2 3 4 5 6 7 8 9 10 Next >>